TPV 250 (Aptivus 250 mg)
Generic Name: tipranavir
Pill imprint TPV 250 has been identified as Aptivus 250 mg.
Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for TPV 250 (Aptivus 250 mg)
Aptivus
- Generic Name:
- tipranavir
- Imprint:
-
TPV 250
- Strength:
- 250 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00597-0003
- Inactive Ingredients:
- alcohol
propylene glycol
gelatin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5719 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
More resources
Aptivus is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
